微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 10.08% | -2.58% | -0.72% | 124/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 10.16% | -1.39% | 9.59% | 125/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 9.27% | -11.87% | -13.96% | 125/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 10.77% | -8.3% | 4.07% | 124/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 10.35% | -14.1% | 0.49% | 123/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 10.3% | -15.87% | -2.06% | 126/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 10.52% | -12.42% | -10.47% | 122/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 11.75% | -11.12% | -2.51% | 124/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 12.05% | 2% | -1.58% | 120/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 12.24% | -6.81% | 1.95% | 121/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 12.01% | 2% | -9.14% | 117/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 13.22% | -6.52% | 0.6% | 122/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 13.14% | 29.74% | -7.08% | 122/132 | 54.78% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 14.14% | -6.81% | 39.63% | 124/132 | 57.29% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 10.13% | -7.02% | -33.26% | 116/132 | 58.42% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 15.17% | 3.7% | 39.32% | 124/132 | 59.59% | 三友医疗 | 90.5% | 行业排名> |
| 2020-06-30 | 10.89% | 2% | -25.57% | 109/132 | 59.94% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 14.63% | 2% | 2% | 117/132 | 56.37% | 正海生物 | 90.78% | 行业排名> |